| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6068279 | The Journal of Allergy and Clinical Immunology: In Practice | 2016 | 13 Pages |
Abstract
Increases and disparities in health care utilization and direct cost by SUA status suggest that patients with SUA require more intensive therapy, greater attention to adherence and comorbidities, more specialist care, and, possibly, personalized treatment approaches including novel biologic treatments.
Keywords
MCOSARPOCsICD-9ICSGERDSABAKPSCKaiser Permanente Southern CaliforniaSevere asthmaPersistent asthmaLong-acting β2-agonistShort-acting β2-agonistsasthma impairmentLeukotriene modifiersemergency departmentSevere Asthma Research Programgastroesophageal reflux diseaseasthma riskasthma guidelinesLABAconfidence intervalRisk ratioAsthma controlInhaled corticosteroidsoral corticosteroids
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Robert S. MD, PhD, Michael MD, MS, Anand A. MBA, PhD, Lei PhD, Wansu MS, Eunice W. MS, Robert Y. ScD, Aniket A. PhD,